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Abstract 
Background 
Swimming in a chlorinated pool results in high exposure levels to disinfection by-products (DBPs), 
which have been associated with an increased risk of bladder cancer. 
Objectives 
By studying molecular responses at the blood transcriptome level we examined the biological 
processes associated with exposure to these compounds. 
Methods 
Whole-genome gene expression and microRNA analysis was performed on blood samples 
collected from 43 volunteers before and 2 hours after 40 minutes swimming in an indoor 
chlorinated pool (PISCINAII study). Exposure to THMs was measured in exhaled breath. Heart 
rate and kcal expenditure were measured as proxies for physical activity. Associations between 
exposure levels and gene expression were assessed using multivariate normal models (MVN), 
correcting for age, body mass index and sex. A Bonferroni threshold at 5% was applied. 
Results 
MVN-models for the individual exposures identified 1,778 genes and 23 microRNAs that were 
significantly associated with exposure to at least one DBP. Due to co-linearity it was not possible 
to statistically disentangle responses to DBP exposure from those related to physical activity. 
However, after eliminating previously reported transcripts associated with physical activity a 
large number of hits remained associated with DBP exposure. Among those, 9 were linked with 
bladder and 31 with colon cancer. Concordant microRNA/mRNA expressions were identified in 
association with DBP exposure for hsa-mir-22-3p and hsa-miR-146a-5p and their targets RCOR1 
and TLR4, both related to colon cancer in association with DBP exposure. 
Conclusions 
Short-term exposure to low levels of DBPs shows genomics responses that may be indicative of 
increased cancer risk. 
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Introduction 
Chlorination is a widely used method to disinfect drinking water as well as swimming pool water. 
Apart from its important role in preventing diseases due to microbial infections, particularly 
drinking water chlorination has also been associated with serious adverse health effects, such as 
bladder cancer and fetal growth retardation [1-4]. Chlorine in combination with organic matter 
yields so called disinfection by-products (DBPs), compounds that can be ingested, absorbed by 
the skin or inhaled [5]. Chloroform (CHCl3), dibromochloromethane (DBCM), 
bromodichloromethane (BDCM) and bromoform (CHBr3) belong to the most common group of 
DBPs, defined as Trihalomethanes (THMs). THMs are volatile and skin permeable compounds and 
can be quantified with validated analytical methods in biological samples, including exhaled air. 
More than 600 DBPs have been identified, including THMs, haloacetic acids (HAAs), trihaloacetic 
acids (THAAs), dichloroacetonitrile (CHCl2CN), chloramines, mutagen X (MX), N-
nitrosodimethylamine (NDMA), haloacetamides (HAcAms), haloacetonitriles (HANs), chloral 
hydrate, etc [6]. The International Agency for Research on Cancer (IARC) has classified several of 
them as possibly carcinogenic to humans [7], which led to the implementation of guidelines for 
DBPs in some countries. The maximum allowed level of total trihalomethanes in the U.S. is 80 
μg/L and in the EU 100 μg/L, although the cutoff differs between EU countries. 
Evidence of DBP toxicity is based on experiments using transgenic bacteria, mammal, rodents 
and in vitro human cells [6]. THMs are formed at the highest concentrations after chlorination [2] 
and long-term exposure has been associated with increased risk of bladder cancer in human 
epidemiological studies [7, 8]. As bladder cancer is the 11nd most common cancer worldwide [9], 
investigating the impact of DBP exposure on bladder cancer risk is highly relevant. Notably also 
an association between DBP exposure and risk of colon cancer has been suggested [2, 10-12].  
In view of the potential carcinogenic effects of DBPs further investigation of the biological 
responses to human exposure is essential for risk assessment and management. In order to 
support evidence-based policy making, a better understanding of the potential molecular 
mechanisms that underpin cancer risks associated with DBP exposure is needed [13]. Studying 
molecular responses on the blood transcriptome level might elucidate in more detail the 
biological processes associated with exposure to these compounds. Additionally, measurements 
of microRNAs, small non-protein-coding RNA molecules that can regulate the expression of 
particular gene products by for instance transcript binding [14], may provide deeper insight into 
underlying gene expression regulatory mechanisms.  
Although THMs represent only a subgroup of DBP, levels of brominated compounds determined 
in exhaled breath after swimming are known to correlate well with concentrations of some DBPs 
in the pool water and also to trichloramine in air. For this reason THM levels have been suggested 
as a non-invasive biomarker of DBP exposure after swimming in chlorinated pools [15]. These 
findings on exhaled bromoform and not exhaled chloroform are consistent with other studies 
[16, 17].  
 In the present study, we aim to study the molecular responses at the blood transcriptome level 
by investigating the biological processes associated with exposure to THMs. In view of the 
existing literature supporting increased risk of bladder cancer associated with THMs, we 
hypothesize that short-term exposure to THMs can already trigger biological responses that may 
contribute to an increased risk of bladder and potentially also colon cancer. 
 
Methods 
Study design 
In total, 116 healthy and non-smoking subjects participated in the experiment, 43 of which were 
included in the transcriptomics analysis. The sample size is sufficient to identify strong effects in a 
regression analysis according to a power calculation test (“pwr” R package). This subpopulation was 
selected following the criteria of not having missing values in the exposure and physical activity 
measurements and having a balanced numbers of females and males (22 females and 21 males) in 
order to reduce potential for confounding in the association between sex-dependent responses and 
exposure. These 43 non-smoking volunteers in the age between 18 and 40 years swam for 40 
minutes in the same indoor chlorinated pool in Barcelona (Spain). The exposure time of 40 
minutes is consistent with a previous study on exposure of swimmers to disinfection by products 
[17]. The subjects, non-professional swimmers, were allowed to rest from swimming but only 
while staying in the pool (6.6±6.7 minutes of resting). Blood was collected from the subjects 
around 30 minutes before and 2 hours after swimming. Blood samples were mixed with RNAlater 
after collection and stored at -80°C within two hours. To control the intake of THMs during the 
experiment, volunteers were asked not to swim for one week before the study and avoid 
showering on the day of the experiment (as it is an important source of THM exposure). During 
the experiment, participants were not allowed to drink tap water. Age (24.0±5.1), gender (51% 
females 49% males) and body mass index (BMI) (24.1±2.8) measurements of the subjects as well 
as temperature (27.9±0.3), and pH (7.5±0.2) of the swimming water were registered.  
Swimming distance and swimming time were registered and volunteers provided a subjective 
score which was intended to reflect their level of physical fatigue and breathlessness after 
swimming. Intensity of physical activity was recorded using a heart rate (HR) monitor (Polar RCX5) 
during the swimming time. The percentage of HR values above 69 percent of the “HRmax”, 
defined as the theoretical maximum HR according to sex and age [18, 19], indicates high intensity 
physical activity (60.5±30.3). In addition, the number of kilocalories (kcal) spent during the 
exercise (210.6±75.2) was estimated with the following formula (Ainsworth et al. 2000): 
𝐾𝑐𝑎𝑙 = 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑘𝑔) ×  
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑠𝑤𝑎𝑚 (𝑚)
𝑚𝑖𝑛
× 𝑡𝑖𝑚𝑒 𝑠𝑤𝑖𝑚𝑚𝑖𝑛𝑔 (ℎ𝑟)𝑋
8.3 (
𝑘𝑐𝑎𝑙
𝑘𝑔⁄
ℎ𝑟 )
46 (𝑚 min )⁄
⁄  
The experiment was approved by the ethics committee (Ethics Committee of Clinical Research 
Parc de Salut Mar, 2013/5034/I) and written informed consent forms from the volunteers were 
obtained. The participants were not informed about their own results. 
DBP Exposure 
Chloroform (CHCl3), bromodichloromethane (BDCM), dibromochloromethane (DBCM) and 
bromoform (CHBr3) were measured in exhaled breath, before and right after swimming.  The 
volunteers breathed deeply three times, retained the air for 10 seconds and breathed into the 
disposable piece of a Bio-VOC™ sampler to obtain 150 ml of alveolar air. Once this alveolar air 
was collected, a screw-in plunger was used to steadily discharge the sample into a sorbent tube 
trap. These stainless steel tubes were 3.5″ (89 mm) long and ¼″ o.d. They were packed with 200 
mg sorbent Tenax TA 35/60 mesh (Markes International Ltd, UK) which was preconditioned using 
helium of 5N grade at 100 ml/min at 320°C for 2 hours and then at 335°C for 30 minutes. In 
posterior conditioning cycles they were reconditioned at 335°C for 20 minutes and the same flow 
carrier gas. One cleaned, the tubes were capped with brass storage caps fitted with PTFE ferrules 
and were stored at 4ºC in a clean environmental free-solvent atmosphere.  
The Bio-VOC sampler was also used to take the indoor air samples (room and swimming pool). 
THMs from indoor air were collected by pulling air through the Bio-VOC sampler using the 
plunger for sample to sorbent tube transfer. This process was repeated 4 times to obtain a total 
volume of 600 ml. After collection, the sorbent tubes were capped with brass storage caps fitted 
with PTFE ferrules and were stored at 4°C in a free-solvent environment air until its analysis. 
THMs were then desorbed and concentrated in a thermal desorption unit equipped with a Unity 
Series 2 Thermal Desorber and an Ultra 50:50 Multi-tube Auto-sampler (Markes International 
Ltd.). They were desorbed at 300 °C for 5 min and the vapors were concentrated into a cold trap 
at -20 °C at 40 ml/min carrier flow (Helium 5N grade) without split. The cold trap, packed with a 
graphitized carbon sorbent for General Purpose by Markes International Ltd., was rapidly heated 
to 300 °C for 5 min with a 7.5 ml/min flow of helium and the THMs were transferred to the gas 
chromatograph (GC) with a split flow of 6 ml/min. Only 20% of the samples in the sorbent tube 
was introduced into the GC column by heating at 200°C. 
The THMs were finally measured in a Gas Chromatograph 7890 (Agilent Technologies) equipped 
with a DB-5MS UI capillary column (60 m x 0.32 mm, 1 m; Agilent J&W GC Columns) at 1.5 ml/ml 
of carrier gas flow (Helium, 5N grade).The GC oven temperature program was hold for 10 min at 
40 °C; 5 °C/min to 150 °C; hold for 10 min; 15 °C/min to 210 °C; and finally hold for 10 min. This 
instrument was coupled to a Mass Spectrometer 5975C Inert XL MSD with a Source in Electronic 
Impact Mode (Agilent Technologies). The GC-MS heat transfer line was heated at 280 °C. The MS 
Source and MS Quadrupol temperatures were 230° C and 150 °C, respectively. The quantitative 
determination was carried out in Selected Ion Monitoring Mode. Dwell time was set at 50 ms for 
each ion scanned. THMs concentrations were expressed as micrograms per cubic meter [15]. 
Correlation between the exposures and between exposure and physical activity measurements 
was calculated using the Spearman method (“cor( )” function from the R package “stats”).  
RNA isolation and microarray hybridization 
Total RNA was isolated from samples (400 µl of whole blood and 1600 µl of RNA later) by using 
RiboPureTM-Blood (Ambion), according to the manufacturer’s instructions. RNA isolated from a 
total of 86 samples was hybridized on Agilent 8x60K Whole Human Genome microarrays for 
mRNA and Sureprint G3 Human V19 miRNA 8 x 60K microarrays for microRNA. Raw data on pixel 
intensities were extracted using Agilent Feature Extraction Software. Four samples failed in the 
mRNA hybridization process. 
Pre-processing of mRNA and microRNA 
The normalization of the gene expression was performed using the Bioconductor 
(github.com/BiGCAT-UM/arrayQC_Module), followed by selection of genes with less than 30% 
flagged bad spots and imputation by k-nearest neighbors (k-NN; k-value 15). The final number of 
probes was 24,893 transcripts. 
For microRNA pre-processing, AgiMicroRna was applied [20]. Control features and microRNAs 
with more than 34% low intensity spots were filtered out, resulting in a total of 278 microRNAs.   
Quality control factor correction 
The study design includes two quality control samples per batch of microarray hybridization for 
both transcriptomics and microRNA analysis. These quality control samples were identical 
biological samples that were distributed across batches, and enable correction of batch-related 
influences on gene expression levels. The pre-processing of quality control samples was 
performed together with the study samples except for the imputation step which was omitted in 
the case of quality control samples. A ratio was calculated by subtracting (since expression values 
were log2 transformed) the median expression of the quality control samples of one day from 
the median expression of all quality control samples of the study. The study samples were 
corrected by addition of these ratios to the samples belonging to the same batch.   
Linear mixed models (LMM) and Multivariate normal model (MVN) 
Before applying the MVN approach, we removed the residual technical noise induced by 
microarray technology from the gene/microRNA expression data: for this, we performed a linear 
mixed model analysis using the “lmer( )” function from the “lme4” R package, including DBP 
exposures as variables of interest together with the random variables (e.g. the date of RNA 
isolation, date of dye labelling and date of microarray hybridization). The residuals, intercept and 
estimated betas of this model were estimated gene-wise using linear mixed models. Then, once 
the parameters from the right-hand side of the linear regression equation are known for each 
gene, their values were used in a second equation in order to calculate the de-noised 
gene/microRNA expression values. A Principal Component Analysis (PCA) of the transcriptomics 
data and the microRNA data was performed in order to visualize the pre- and post-swimming 
condition. 
We ran a MVN using the “gls( )” function from the R package “nlme” to find associations between 
gene/ microRNAs expression and THMs exposure. The multivariate normal distribution was 
parameterized using a mean vector (μ) and a covariance matrix (Σ). Σ represents the variance-
covariance across the two observations per subject (before and after swimming).  
In the model Y ~ MVN (μ, Σ), Y represents the gene/ microRNAs expression, where Ypre refers to 
the expression of the samples collected before swimming and Ypost to the samples after 
swimming. The THMs were modelled individually, so CHCl3, BDCM, DBCM, CHBr3, and as a sum 
of all brominated compounds, BrTHMs (BrTHMs = BDCM + DBCM + CHBr3) as well as the grand 
total of all THMs measured, tTHM (tTHM = CHCl3+ BDCM + DBCM + CHBr3). The measured 
exposure levels were centered around the mean exposure level before swimming. The model 
formulation includes the individual mean of each exposure and the increase of the exposure 
between the individual mean and the centered mean. The last one is the variable of interest that 
has been used for further analysis. In order to implement the MVN, the IDs from the different 
subjects were used as the grouping factor in the general correlation structure (“corSymm”), and 
the pre-/post-swimming condition was implemented by the constant variance function structure 
(“varIdent”). 
In addition, we ran a model with experiment (pre- vs post-swimming) as variable of interest 
instead of the individual THMs in order to assess the changes in gene expression due to 40 
minutes of swimming in the chlorinated swimming pool. The analysis gave the almost the same 
number of hits associated with pre-/post-swimming with individual exposures analysis and 
therefore these genes were not further analyzed. 
Sensitivity analysis assessing potential confounders such as temperature and pH of water and 
temperature of air was performed by running models with and without such variables.  
Regression coefficients and p-values were estimated from each model (individual exposures and 
sum of them). P-values were adjusted using Bonferroni threshold at 5%. 
Due to the relatively small number of subjects in the experiment, there is a risk that some outliers 
drive the results. In order to avoid this potential risk, the highest and lowest expression levels 
were truncated 5%, 10% and 20% (capping). This sensitivity analysis was performed for both 
mRNA and microRNA datasets.  
Integration of genome-wide gene and microRNA expression data 
We generated lists of significant hits in association with DBP exposures identified in the MVN 
model, for transcriptomics and microRNA analysis independently. miRTarBase database was used 
to identify the relationships between significantly modified microRNAs and gene expressions. 
The database only includes microRNA-target gene interactions that are collected by manually 
surveying relevant literature and have been validated experimentally [21]. The significantly 
expressed microRNAs from the MVN model were used to identify target mRNA candidates. These 
mRNA candidates were exported and compared with the list of significant transcripts generated 
by the MVN model. These genes were displayed in Cytoscape [22] in order to visualize the 
interactions between up- or down-regulated mRNAs and microRNAs in association with DBP 
exposure. Significantly expressed genes with negative correlations between the mRNA and 
microRNA expressions were selected for further evaluation.   
Genes associated with bladder and colon cancer 
The genes that were identified to be significantly expressed in association with THM exposure 
were used as input for the Comparative Toxicogenomics Database in order to assess their 
potential role in the development of bladder and colon cancer. The search was focused on Homo 
sapiens. References with “direct evidence”, defined as “a gene that may be a biomarker of a 
disease or play a role in the etiology of a disease”, were selected [23].  
 
 
Genes associated with physical activity and THM exposure 
In order to enable correction for genes that are potentially modulated by physical activity, the 
biomedical mindmap “Coremine” (https://www.coremine.com/) was used to find connections 
between gene expression and physical activity using the term “'motor activity (alias Physical 
Activity)'”. The same search was performed for each individual DBP exposure, using the terms 
'Chloroform (chemical)’, ‘bromodichloromethane (chemical)’, 'chlorodibromomethane (alias 
dibromochloromethane)' and ‘bromoform (chemical)’. Next, we assessed the overlap with the 
significant hits from the MVN by comparing both lists in a venn diagram.  
Pathway analysis of gene expression 
For the biological interpretation of genes deregulated in association with THM exposure, we used 
the lists of significant transcripts for each model after Bonferroni correction as input for pathway 
analysis using ConsensusPathDB [24]. A background list comprising the total list of genes from 
the dataset after pre-processing was used. 
 
Results 
DBP exposure 
Exposures to brominated compounds showed considerable inter-correlation (ranging from 0.64-
0.91). Also, the correlation between exposures to chloroform and to the sum of THM was very 
high (0.96 and 0.99 before and after swimming respectively) (Supplementary material Table S1). 
All exhaled air THM levels were significantly increased after swimming (paired T-test) (Table 1). 
The correlation between THM exposure levels and the various parameters of physical activity 
was also high (0.73-0.86 for Kcal and heart rates) (Supplementary material Table S2). Since it 
appeared impossible to disentangle physical activity from DBP exposure due to the high 
correlation between both variables, the final MVN model was adjusted only for the confounders’ 
sex, age and BMI. The water quality parameters of the swimming pool are described in 
Supplementary Material Table S3. 
 
 
 
 
 
Table 1. Exposure levels measured in exhaled breath before and after swimming (N=43).  
Compounds 
Pre-swimming Post-swimming Paired t-test 
Mean ± SD (µg/m3) Mean ± SD (µg/m3) P-value 
CHCl3 0.41±0.26 11.58±4.78 < 2.2e-16 
CHBr3 0.03±0.02 0.11±0.07 < 2.2e-09 
BDCM 0.06±0.06 2.49±1.08 < 2.2e-16 
DBCM 0.02±0.03 0.53±0.28 < 2.2e-14 
BrTHMs 0.12±0.10 3.13±1.41 < 2.2e-16 
tTHMs 0.52±0.34  14.72±5.90 < 2.2e-16 
 
Changes in transcriptome and microRNA levels as a consequence of swimming 
Figure 1 A) shows a Principal Component Analysis (PCA) of the transcriptomics data (24 893 
transcripts) and Figure 1 B) of the microRNA data (278 microRNAs). The expression values were 
corrected for batch effect using linear mixed model analysis as described in the methods section. 
To some degree, with respect to the transcriptome data the condition ‘pre-swimming’ (white) 
can be discriminated from the condition ‘post-swimming’ (black) while this is relatively less clear 
for the microRNA dataset.  
 
Figure 1. PCA plots of the gene expression before swimming (white) and after swimming (black). 
A) for mRNA and B) for microRNA. N=41 in A) and N=43 in B). 
The number of Bonferroni significant hits associated with each individual THM exposure using 
the confounder adjusted MVN models are displayed in Figure 2 (A) for transcriptomics and B) for 
microRNAs). A considerable number of similar hits are shared among the associations with all 
THM exposures (721 genes and 7 microRNAs).  A relatively large number of hits are in common 
for brominated exposures (153 genes and 8 microRNAs). To a lesser extent, hits uniquely 
associated with each individual exposure were found. BrTHMs show only a few hits not common 
with the individual brominated compounds so it has been excluded from Figure 2 in order to 
make it more readable.     
 Figure 2. Venn diagram of Bonferroni significant hits, adjusted for sex, age and BMI. CHCl3 = 
chloroform; BDCM = bromodichloromethane; DBCM = dibromochloromethane; Br3CH = 
bromoform (N=41).  
 
Capping 
Truncation of the omic distribution demonstrates robustness of the MVN hits for both 
transcriptomics and microRNA analysis. The total number of hits per capping parameter (5, 10, 
20%) is described in Supplementary Material Table S4.  
MicroRNA/transcript integration 
Figure 3 shows the numbers of Bonferroni-significant expressions associated with each individual 
exposure for microRNAs that target genes significantly expressed in association with THM 
exposures. In total 9 microRNAs out of a total of 23 microRNAs were found that were significantly 
associated with at least one exposure: 63 for CHCl3, 43 for BDCM, 29 for DBCM, 43 for BrTHMs 
and 57 for tTHMs. Heatmaps of the correlations between Bonferroni significant transcripts and 
microRNAs are displayed in Supplementary Material Figure S1 to Figure S6. Around 60% of the 
expressed genes significantly associated with BrTHMs that are also targeted by significantly 
expressed microRNAs show an inverse mRNA-microRNA relationship. In the case of CHCl3 the 
proportion of such negative correlations is around 50%. Some of these significant genes (targeted 
by significant microRNAs) are involved in pathways related to cancer processes (Supplementary 
Material Table S5), such as apoptosis modulation and signaling, transcriptional misregulation in 
cancer, and TNF-α pathways. Figure 4 presents the Cytoscape networks for the microRNAs and 
the mRNA targets that were significantly associated with exposures to BrTHMs and to CHCl3. 
These networks present IGF1R, NCOA4, MAPRE1, ITPRIP, EPHB4, ACSL1, ZNF217, FRAT2, ARPC5, 
KPNB1 and NRD1, all up-regulated in association with DBP exposure and involved in cancer-
related processes,  and showing a negative correlation with the expression of the microRNAs that 
target them. 
 
Figure 3. Number of Bonferroni-significant gene expressions associated with individual exposures 
(N=41). 
 
Figure 4. Cytoscape network showing interactions of microRNAs and genes. Up-/down-
regulation  in association with exposure for BrTHMs (A) and CHCl3 (B) and positive/negative 
correlation between mRNA-microRNA. Can be found at:  
http://web.tgx.unimaas.nl/shared_files/aespin/Piscina/Figure_4 
Genes associated with bladder cancer and colon cancer 
Some of the significantly expressed genes in association with DBP exposures have previously 
been linked to bladder cancer (9 genes) and colon cancer (31 genes). A hypergeometric test 
shows a significant overlap for colon cancer (p-value 0.004) but not for bladder cancer (p-value 
0.227). Supplementary Material Table S6 displays the regression coefficients for each exposure 
and presents correlation levels with their corresponding p-values for bladder and colon cancer. 
The 9 significant genes also associated with bladder cancer are  SLC19A1 [25], CREBBP [26], GSTP1 
[27-29], STAG2 [30-32], KMT2C [26], ASXL2 [30], SOD2 [33, 34] and RASSF1 [35].  
In case of colon cancer, the 31 genes which are found to be involved in cancer are involved in the 
RAGE-, FoxO-, HIF-1-, DNA damage- and interleukin-related pathways. Two genes deregulated in 
association with THM exposure, were negatively correlated with two microRNAs and at the same 
time regulated into the direction of colorectal cancer risk. Firstly, RCOR1 is a colon cancer-related 
gene that is significantly associated with BrTHMs exposure and shows a negative correlation with 
the microRNA hsa-miR-22-3p, also significantly associated with BrTHMs exposure (correlation 
gene-microRNA= -0.33, p-value 2.33E-03). Secondly, TLR4 is also related to colon cancer and is 
significantly associated with CHCl3 exposure. It shows a negative correlation with microRNA 146a-
5p, which is significantly associated with CHCl3 exposure (correlation gene-microRNA= -0.08, p-
value 0.50). Figure 5 shows a 3D plot with the TLR4 and RCOR1 gene expression and hsa-miR-
146a-5p and hsa-miR-22-3p expression against exposure levels of CHCl3 (Figure 5 A) and BrTHMs 
(Figure5B). 
 
 
Figure 5. 3D plot for TLR4  gene and hsa-miR-146a-5p, both significantly associated with CHCl3 
(A) and RCOR1 and hsa-miR-22-3p, both significantly associated with BrTHMs exposure (B) 
(N=41).   
Genes associated with physical activity and THM exposure according to literature 
We found some overlap between the hits reported in literature for physical activity and the 
significant genes from MVN (between 17% and 19% depending on the exposure). Only significant 
genes associated with CHCl3 exposure showed an overlap: 32 significant genes associated with 
CHCl3 were found also in the literature and do not overlap with physical activity. 
Pathway analysis  
In view of the difficulty to separate the exposure effects from effects induced by physical activity, 
we deleted the genes that have been associated with physical activity in the literature (Coremine 
mindmap) from the input list for pathway analysis. Table 2 shows the resulting list of pathways 
found in association with DBP exposure, grouped according to common pathways among 
exposures. ConsensusPathDB analysis provided a large number of deregulated cancer-related 
pathways such as miR-targeted genes in squamous cell carcinoma, and various cancer-related 
pathways (SUMO, RHO GTPases, WNT, etc).  Table 3 shows the pathways associated with 
chloroform exposure that were common with those from literature and did not overlap with 
physical activity. We found relevant pathways related to nucleotide excision repair and p73 
(protein related to the p53 tumor protein). Supplementary Material Table S7 displays the full list 
(before excluding genes related to physical activity). 
 
Discussion 
Exposure to disinfection by-products present in swimming water has been associated with 
adverse health outcomes such as increased risk of bladder cancer, and in order to gain improved 
understanding of the potential mechanisms involved in this association we evaluated the 
transcriptome and microRNA responses before and after swimming in a chlorinated indoor pool. 
After denoising the data from technical variables using linear mixed models, associations 
between gene/ microRNA expression levels and exposures to DBPs were established using 
multivariate normal models. The stringent multiple hypothesis testing method and cutoff chosen 
for the analysis (Bonferroni <0.05) reduces the chance of identifying false positives. In view of 
the consistently reported link between bladder cancer risk and DBPs, we evaluated the 
established molecular responses in the context of this association. Previous publications reported 
the impact of THMs long-term exposure [7, 8]. In this study, we aim to assess the molecular 
changes occurring as a direct consequence of short-term exposure. Besides the relatively small 
population, significant genomics responses that induce up or down regulation in cancer-related genes 
have been identified. 
From the total of list of genes that were significantly associated with DBPs, we identified nine 
genes significantly associated with DBP exposure that have previously been linked to bladder 
cancer (Table S5). The protein encoded by SLC19A1 is a transporter of folate, and the expression 
of this gene was approximately 9-fold higher expressed in bladder tumor relative to normal 
bladder tissue [25]. In our study, the SLC19A1 expression was highly correlated with exposure to 
tTHMs (0.52, p-value 5.293e-07). CREBBP, a gene involved in the transcriptional co-activation of 
a large variety of transcription factors, was found to have genetic aberrations in individuals with 
bladder cancer [26]. According to the literature, CREBBP up-regulates hTERT activity, promoting 
lung cancer growth [36]. In our study we found a positive association between CREBBP and all 
DBP exposures (range of regression coefficients 0.05-6.37). Although this gene is linked to 
bladder cancer, having no information on the directionality of the gene activity makes it is difficult 
to interpret the consequence of a positive correlation with exposure with regard to the impact 
on cancer risk.  GSTP1 is a phase II enzyme which is involved in the detoxification of metabolites 
with carcinogenic properties. Down-regulation of GSTP1 has been suggested as a possible early 
event in prostate cancer development [37]. On the other hand, in vitro studies have shown an 
over-expression of GST in resistant human bladder cancer cells [29]. Its expression has also been 
found to be low in brain cancer patients [38]. GSTP1 has negative regression coefficients in our 
findings (ranging from -0.03 to -3.54). A down regulation of GSTP1 detoxification is generally 
interpreted as a carcinogenic risk in view of the reduced capacity to eliminate reactive and 
potentially carcinogenic metabolites. SOD2 is a member of the superoxide dismutase family. The 
stage and grade of bladder cancer was found to correlate positively with SOD2 gene expression 
levels [33]. We found a positive association between SOD2 and exposure levels (regression 
coefficients ranging from 0.03 to 4.36), which suggests that exposure to DBP drives SOD2 activity 
in the same direction as observed in bladder cancer cells. Finally, RASSF1 is a tumor suppressor 
gene and epigenetic silencing of this gene has been associated with advanced tumor stages in 
bladder cancer patients [35]. The gene shows a negative association with DBP exposure levels 
(regression coefficients from -0.02 to -1.88), indicating a down-regulation of the gene expression 
when subjects are exposed to high levels of DBPs. It should be noted that in our study we are 
measuring gene expression changes after short-term exposure to DBP, whereas the gene 
expression data reported in the literature in most cases report on basal levels in cancerous tissues 
and cells. Even when the observed transcriptome responses seem to go in the same direction as 
found in the literature, interpretation of gene expression changes in terms of increased cancer 
risk should be done with some reservation.  
The study of microRNAs as gene regulators in cancer development has tremendously improved 
the diagnosis and personalized care of patients. As microRNAs are very stable and much more 
resistant to RNAase degradation as compared to mRNAs, these small molecules have a great 
potential as biomarkers of early disease [39]. In view of the important function of microRNAs in 
the regulation of oncogenes and tumor suppressor genes, studying co-expressed and targeted 
genes may further enhance the understanding of molecular mechanisms that could explain the 
observed link between DBP exposure and cancer risk. 
In our analyses, we found that the bladder cancer associated gene ASXL2, was positively 
associated with DBP-exposure, whereas the microRNA targeting this gene, hsa-miR-326, was 
negatively associated with exposure. Hsa-miR-326 is known to exert an anticancer effect [40-45] 
and is found to be downregulated in primary human lung cancer and non-small lung cancer cell 
lines [46]. ASXL2 encodes a chromatin protein involved in transcriptional activation and silencing. 
Although it may promote breast cancer [47] and cervical cancer [48], the impact of increased 
ASXL2 expression or its mutational inactivation on bladder cancer risk is inconclusive [30, 49].  
Even though our study was primarily focused on the identification of molecular changes linking 
exposure to DBP to bladder cancer, we also observed expression changes of genes that have 
previously been associated with colon cancer risk. Given the fact that the association between 
exposure and colon cancer risk is less consistent in literature, it is remarkable that we found even 
more genes linked to colon cancer as compared to bladder cancer (p-value 0.004 from a 
hypergeometric test). The 31 genes we identified are involved in RAGE-, FoxO-, HIF-1-, DNA 
damage- and interleukin-related pathways. In view of the large number of genes it is difficult to 
interpret the overall outcome in terms of directionality towards cancer risk. In addition to this 
transcriptome response, we found 4 microRNAs that were significantly associated with DPB 
exposure. Two of these microRNAs may target genes from the list of 31 genes associated with 
colon cancer. This applies for the microRNAs hsa-miR-22-3p and hsa-miR-146a-5p and their 
target genes RCOR1 and TLR4, respectively. 
The microRNA hsa-miR-22-3p has a tumor suppressor role [50] and it was found to be down-
regulated in colon cancer [51, 52], hepatocellular carcinoma [53] and osteosarcoma [54]. As 
shown in TableS5 B, the expression of this microRNA in association with THM exposure goes into 
the opposite direction, suggesting that cancer risk would be increasing with increasing exposure. 
Furthermore, the microRNA hsa-miR-22-3p is expressed in the opposite direction to its target 
gene RCOR1, an oncogene that has also been linked with colon cancer [55]. Thus, increased 
exposure is found to result in higher expression of RCOR1, which is again supporting a potentially 
increased cancer risk as a consequence of exposure to DBPs. 
Hsa-miR-146a-5p acts as a tumor-suppressor gene by inhibiting proliferation of colon cancer cells 
[56]. The oncogene TLR4 is targeted by hsa-miR-146a-5p and both TLR4 and hsa-miR-146a-5p 
show a negative correlation. Increased TLR4 expression has been associated with colon cancer 
[57-59] and in our study, TLR4 expression increased with increasing exposure levels to all DBPs. 
This implies that high exposure to DBPs changes the expression of hsa-miR-146a-5p and TLR4 the 
same direction as observed in colon cancer. 
Exposures to brominated compounds show the highest regression coefficients for genes 
associated with bladder and colon cancer (Supplementary Material Table S6). In addition, also 
the most significant pathways found in ConsensusPathDB are associated with exposure to these 
compounds. These findings suggest a stronger toxic effect of brominated compounds as 
compared to chloroform. Previous studies have also reported an increased frequency of 
micronucleated lymphocytes after swimming linked to brominated compounds and not 
chloroform [17].  
THMs is one of the most prevalent classes of DBPs, reason why it has been widely used in 
epidemiological studies as surrogates of total DBP content,  together with validated methods of 
analysis from biological samples including measurements in exhaled air [2, 60]. In view of the 
large number of DBP species, THMs represent however only a small but relevant subgroup. The 
genomics responses observed in this study are identified in correlation analysis with THMs 
exposure and therefore, these findings cannot be translated directly to other DBPs with 
important toxicological effects [4]. Nevertheless, increased levels of BrTHMs in exhaled breath 
were significantly correlated to total organic carbon (Spearman correlation=−0.22) and some 
DBPs from the pool water such as BrTHMs (0.48), THAAs (−0.34), CHCl2CN (−0.40), C3H3Cl3O 
(−0.42), chloramines, total organic chlorine and total organic bromine [15]. This demonstrates 
the potential of BrTHMs in exhaled breath as a valid biomarker of DBPs exposure measurements 
in swimming pools containing bromide source water. Regarding the contribution of DBPs to 
cancer risk, further analysis including a wider range of DPBs species should be carried out in order 
to provide a more specified assessment. 
Separating DBP exposure effects from those induced by physical activity represents a challenge 
in this experimental design. As 59% of the genes that we identified have also been associated 
with physical activity, we removed all physical activity-related genes reported in literature. In 
view of the large number of hits remaining after this removal and the relatively large number of 
cancer-related pathways generated from this corrected gene list, we conclude that these findings 
reflect the response to DPB exposure rather than to physical activity.  
 
Conclusions 
In conclusion, the results of this study show that a short period of swimming in a chlorinated pool 
can already produce changes in gene and microRNA expression. A total of 1,778 unique 
transcripts were significantly associated with exposures to CHCl3, BDCM, DBCM, CHBr3 and the 
sum of BrTHMs and THMs. The concomitant analysis of microRNAs resulted in the identification 
of 23 unique microRNAs associated with the same exposures. Nine significantly expressed genes 
could be linked to bladder cancer risk and 31 to colon cancer risk. Both microRNA hsa-miR-22-3p 
and its target gene RCOR1 were significantly related to DBP exposure, and regulated into the 
same direction as in colon cancer. The same applies to the significantly regulated hsa-miR-146a-
5p and its target gene TLR4.  
This study thus shows that gene expression and miRNA changes induced by short-term exposure 
to low levels of DBPs in a chlorinated pool may be indicative for increased risk of colon and 
bladder cancer. 
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Table S1. Correlation between the different THMs in exhaled breath, before and after swimming 
(Spearman method), N=43. 
  
Table S2. Correlation between the different DBP compounds and the different physical activity 
measurements (Spearman method), N=43. A) Before and after swimming. B) After swimming. 
A) 
 
B) 
 
 
Table S3. Characteristics and exposure levels measured in swimming pool water 
Swimming pool water  
Compound family Compound Mean±SD 
Trihalomethanes (µg/L) Chloroform (CHCl₃)     37.76±7.53 
Compound CHCl3 BDCM DBCM CHBr3 BrTHMs tTHMs Compound CHCl3 BDCM DBCM CHBr3 BrTHMs tTHMs
CHCl3 1.00 CHCl3 1.00
BDCM 0.57 1.00 BDCM 0.79 1.00
DBCM 0.22 0.67 1.00 DBCM 0.53 0.91 1.00
CHBr3 0.27 0.70 0.64 1.00 CHBr3 0.37 0.75 0.91 1.00
BrTHMs 0.46 0.95 0.81 0.83 1.00 BrTHM 0.71 0.99 0.96 0.81 1.00
tTHMs 0.96 0.73 0.40 0.46 0.66 1.00 tTHM 0.99 0.86 0.62 0.45 0.79 1.00
Pre-swimming Post-swimming
Variables CHCl3 BDCM DBCM CHBr3 BrTHMs tTHMs Kcal HR max 69 Breathless Fatigue Swim time Distance
CHCl3 1.00
BDCM 0.92 1.00
DBCM 0.84 0.95 1.00
CHBr3 0.78 0.90 0.92 1.00
BrTHMs 0.90 0.99 0.97 0.93 1.00
tTHMs 0.99 0.95 0.88 0.82 0.93 1.00
Kcal 0.86 0.86 0.84 0.76 0.85 0.86 1.00
HR max 69 0.83 0.84 0.83 0.73 0.84 0.84 0.87 1.00
Breathless 0.62 0.66 0.64 0.59 0.65 0.64 0.54 0.70 1.00
Fatigue 0.71 0.74 0.74 0.68 0.74 0.72 0.74 0.77 0.68 1.00
Swim time 0.81 0.83 0.83 0.75 0.83 0.81 0.93 0.85 0.52 0.68 1.00
Distance 0.86 0.86 0.85 0.76 0.85 0.86 0.98 0.87 0.56 0.74 0.94 1.00
Variables CHCl3 BDCM DBCM CHBr3 BrTHMs tTHMs Kcal HR max 69 Breathless Fatigue Swim time Distance
CHCl3 1.00
BDCM 0.79 1.00
DBCM 0.53 0.91 1.00
CHBr3 0.37 0.75 0.91 1.00
BrTHMs 0.71 0.99 0.96 0.81 1.00
tTHMs 0.99 0.86 0.62 0.45 0.79 1.00
Kcal 0.47 0.40 0.32 0.19 0.36 0.47 1.00
HR max 69 0.38 0.41 0.34 0.16 0.39 0.41 0.21 1.00
Breathless 0.33 0.46 0.41 0.42 0.44 0.38 -0.01 0.48 1.00
Fatigue 0.13 0.22 0.25 0.23 0.22 0.17 0.07 0.29 0.42 1.00
Swim time 0.05 0.17 0.23 0.16 0.18 0.06 0.48 0.08 -0.11 -0.20 1.00
Distance 0.46 0.44 0.35 0.21 0.40 0.47 0.88 0.23 0.01 0.04 0.61 1.00
Bromodichloromethane (BDCM) 8.17±2.34 
Dibromochloromethane (DBCM) 2.81±1.06 
Bromoform (CHBr₃)   1.07±0.54 
Brominated THMs (BrTHM)  10.88±5.15 
Total THMs (TTHM)     49.82±9.14 
Haloacetic acids (µg/L) 
Dichloroacetic acid (DClAA)   29.67±10.25 
Trichloroacetic acid  (TClAA)  59.95±11.11 
Bromochloroacetic acid (BrClAA) 5.1±1.68 
Dibromoacetic acide (DBrAA)  1.58±0.71 
Dibromochloroacetic acid 
(DClBrAA) 12.22±5.3 
Haloacetonitriles (µg/L)  
Dichloroacetonitrile (C₂HCl₂N)   7.03±1.95 
Bromochloroacetonitrile 
(CHBrClCN) 3.73±0.76 
Chloramines (mg/L) 
Monochloramine (NH₂Cl)   0.31±0.24 
Dichloramine (NHCl₂)  0.25±0.2 
Trichloramine (NCl₃)   0.11±0.3 
Others 
Haloketone (µg/L) (C₃H₃Cl₃O)  2.31±0.85 
Total organic carbon 
(mg/L)  (NPOC) 2.76±1.35 
Free chlorine (mg/L)   (FCl)  1.33±0.38 
Total Organic Chlorine (TOCl)  0.07±0.01 
Total Organic Halides (TOX)  0.47±0.03 
N-nitrosodimethylamine 
(NDMA) 10.84±1.6 
pH    7.54±0.24 
Temperature     27.89±0.31 
 
 
 
 
 
 
Table S4. Sensitivity analysis for capping. Bonf=Bonferroni correction, N=41 in A) and N=43 in B). 
A) Transcriptomics 
 B) MicroRNA 
 
 
Figure S1. Figure S1. Heatmap showing correlations between Bonferroni significant transcripts 
and microRNAs for CHCl3. Can be found at:  
http://web.tgx.unimaas.nl/shared_files/aespin/Piscina/Figure_S1.docx 
Figure S2. Figure S2. Heatmap showing correlations between Bonferroni significant transcripts 
and microRNAs for BDCM. Can be found at:  
http://web.tgx.unimaas.nl/shared_files/aespin/Piscina/Figure_S2.docx 
Figure S3. Figure S3. Heatmap showing correlations between Bonferroni significant transcripts 
and microRNAs for DBCM. Can be found at:  
http://web.tgx.unimaas.nl/shared_files/aespin/Piscina/Figure_S3.docx 
Figure S4. Figure S4. Heatmap showing correlations between Bonferroni significant transcripts 
and microRNAs for CHBr3. Can be found at:  
http://web.tgx.unimaas.nl/shared_files/aespin/Piscina/Figure_S4.docx 
Figure S5. Figure S5. Heatmap showing correlations between Bonferroni significant transcripts 
and microRNAs for tTHMs. Can be found at:  
http://web.tgx.unimaas.nl/shared_files/aespin/Piscina/Figure_S5.docx 
Figure S6. Figure S6. Heatmap showing correlations between Bonferroni significant transcripts 
and microRNAs for BrTHMs. Can be found at:  
http://web.tgx.unimaas.nl/shared_files/aespin/Piscina/Figure_S6.docx 
All transcripts Capping 95%-5% Capping 90%-10% Capping 80%-20% Full vs 95%-5% Full vs 90%-10% Full vs 80%-20%
Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05
CHCl3 1625 1471 1185 606 1349 1069 537
BDCM 1552 1387 1065 495 1272 976 444
DBCM 1315 1138 865 403 1037 773 336
CHBr3 768 595 430 237 510 316 136
BrTHMs 1517 1334 1034 474 1207 948 421
tTHMs 1657 1492 1191 608 1350 1081 538
Exposure
All transcripts Capping 95%-5% Capping 90%-10% Capping 80%-20% Full vs 95%-5% Full vs 90%-10% Full vs 80%-20%
Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05 Bonf<0.05
CHCl3 20 17 12 7 15 11 6
BDCM 20 18 11 4 15 8 2
DBCM 17 12 8 3 10 6 2
CHBr3 7 6 2 2 5 2 1
BrTHMs 19 17 9 4 14 6 2
tTHMs 19 18 13 7 14 11 5
Exposure
Table S5. Full list of pathway from significant genes targeted by significant microRNAs using 
ConsensusPathDB.  
q-value pathway 
0.045747 il-7 signal transduction 
0.045747 nf-kb signaling pathway 
0.045747 Apoptosis Modulation and Signaling 
0.045747 Transcriptional misregulation in cancer - Homo sapiens  
0.045747 IKK complex recruitment mediated by RIP1 
0.045747 FSH 
0.045747 Prion diseases - Homo sapiens  
0.045747 miR-targeted genes in lymphocytes - TarBase 
0.045747 TNFalpha 
0.045747 Measles - Homo sapiens  
0.045747 TRIF-mediated programmed cell death 
0.045747 TLR NFkB 
0.045747 Hepatitis B - Homo sapiens  
0.045747 Signaling Pathways in Glioblastoma 
0.045747 miR-targeted genes in epithelium - TarBase 
0.047017 IL2 
0.047811 EPHB-mediated forward signaling 
0.047811 TRAF6 mediated induction of TAK1 complex 
0.047811 Toll-like receptor signaling pathway - Homo sapiens  
0.047811 CXCR4-mediated signaling events 
0.047811 NF-kappa B signaling pathway - Homo sapiens  
0.047811 PECAM1 interactions 
0.047811 IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation 
0.047811 mechanism of protein import into the nucleus 
0.047811 Downstream TCR signaling 
0.047811 TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling 
0.047811 TRIF-mediated TLR3/TLR4 signaling  
0.047811 MyD88-independent TLR3/TLR4 cascade  
0.047811 Toll Like Receptor 3 (TLR3) Cascade 
0.047811 B Cell Receptor Signaling Pathway 
0.047811 Pathways in cancer - Homo sapiens  
0.047811 Focal adhesion - Homo sapiens  
0.047811 IL3 
0.047811 Nucleotide-binding domain 
0.047811 miR-targeted genes in muscle cell - TarBase 
0.047811 Pathogenic Escherichia coli infection - Homo sapiens  
0.047811 Ligand-dependent caspase activation 
0.048355 Apoptosis 
0.051554 Ephrin signaling 
0.051554 Programmed Cell Death 
0.051665 Influenza Life Cycle 
0.051665 Endocytosis - Homo sapiens  
0.051926 Toxoplasmosis - Homo sapiens  
0.051926 Kit receptor signaling pathway 
0.051926 Leptin 
0.051926 Activated TLR4 signalling 
0.051926 PI3K-Akt signaling pathway - Homo sapiens  
0.054684 Apoptosis Modulation by HSP70 
0.055185 Influenza Infection 
0.055185 regulation of bad phosphorylation 
0.055185 EPH-ephrin mediated repulsion of cells 
0.055185 Primary Focal Segmental Glomerulosclerosis FSGS 
0.055185 EPH-Ephrin signaling 
0.055185 Coregulation of Androgen receptor activity 
0.055185 TCR signaling 
0.055185 Methionine and cysteine metabolism 
0.055185 Regulation of toll-like receptor signaling pathway 
0.055185 Toll Like Receptor 4 (TLR4) Cascade 
0.055879 IGF-Core 
 
 
Table S6. Regression coefficients and correlation levels for genes associated with bladder cancer 
(A) and colon cancer (B) from literature and the targeted microRNA.  
A) 
 
B) 
 
 
 
 
 
Features CHCl3 BDCM DBCM CHBr3 BrTHMs tTHMs Correlation tTHMs p-value Correlation BrTHMs p-value
SLC19A1 0.051 0.228 1.002 4.858 0.180 0.040 0.521 5.29E-07 0.521 5.29E-07
CREBBP 0.062 0.285 1.293 6.367 0.227 0.049 0.509 1.06E-06 0.509 1.06E-06
GSTP1 -0.033 -0.146 -0.665 -3.530 -0.117 -0.026 -0.352 1.20E-03 -0.352 1.20E-03
STAG2 0.053 0.254 1.170 5.858 0.203 0.043 0.441 3.43E-05 0.441 3.43E-05
KMT2C 0.037 0.166 0.751 - 0.132 0.029 0.426 6.62E-05 0.426 6.62E-05
ASXL2 0.035 0.162 0.748 - 0.130 0.028 0.472 7.41E-06 0.472 7.41E-06
SOD2 0.042 0.196 0.898 - 0.157 0.034 0.377 4.90E-04 0.377 4.90E-04
RASSF1 -0.019 -0.087 - - -0.069 -0.015 -0.364 7.65E-04 -0.364 7.65E-04
POR - 0.152 0.723 - 0.123 - - - 0.397 2.22E-04
hsa-miR-326 -0.034 -0.139 -0.558 -2.598 -0.108 -0.026 -0.251 2.26E-02 0.251 2.30E-02
Features CHCl3 BDCM DBCM CHBr3 BrTHMs tTHMs Correlation tTHMs p-value Correlation BrTHMs p-value
ABCA1 0.027 0.119 0.526 2.587 0.094 0.021 0.500 1.78E-06 0.500 1.78E-06
ABCA1 0.053 0.246 1.112 5.599 0.196 0.042 0.516 6.85E-07 0.516 6.85E-07
ABCC5 0.040 0.184 0.845 7.235 0.147 0.032 0.431 5.28E-05 0.431 5.28E-05
ABCC5 0.067 0.310 1.415 6.401 0.247 0.054 0.492 2.61E-06 0.492 2.61E-06
ABCG1 0.066 0.293 1.299 6.108 0.232 0.052 0.571 2.06E-08 0.571 2.06E-08
ALOX5 0.059 0.269 1.216 - 0.214 0.047 0.481 4.88E-06 0.481 4.88E-06
AMACR 0.054 0.248 1.116 - 0.197 0.043 0.380 4.30E-04 0.380 4.30E-04
ATP7A 0.042 0.195 0.875 4.450 0.155 0.034 0.474 6.75E-06 0.474 6.75E-06
BCL2 -0.036 -0.157 -0.672 -3.397 -0.123 -0.028 -0.348 1.34E-03 -0.348 1.34E-03
CALR 0.034 -0.122 -0.558 -2.777 -0.097 -0.020 -0.413 1.13E-04 -0.413 1.13E-04
CDKN1B -0.043 0.160 0.725 - 0.128 0.028 0.399 2.05E-04 0.399 2.05E-04
FADS1 -0.029 -0.187 - - -0.148 -0.034 -0.401 1.92E-04 -0.401 1.92E-04
FZD2 0.065 -0.129 - - -0.102 -0.023 -0.323 3.08E-03 -0.323 3.08E-03
IL1RN 0.064 0.296 1.316 6.420 0.235 0.052 0.547 1.08E-07 0.547 1.08E-07
JUN 0.041 0.292 1.300 6.620 0.231 0.051 0.491 2.81E-06 0.491 2.81E-06
KDM5B 0.064 0.180 0.788 3.782 0.142 0.032 0.476 6.05E-06 0.476 6.05E-06
LRG1 0.082 0.293 1.327 6.650 0.233 0.051 0.530 3.04E-07 0.530 3.04E-07
MMP9 0.071 0.368 1.627 8.033 0.291 0.065 0.474 6.85E-06 0.474 6.85E-06
NAMPT 0.053 0.336 1.541 7.684 0.268 0.057 0.495 2.24E-06 0.495 2.24E-06
NOTCH1 0.053 0.234 1.036 - 0.185 0.042 0.525 4.11E-07 0.525 4.11E-07
RCOR1 0.019 0.252 1.143 5.601 0.201 0.043 0.424 7.19E-05 0.424 7.19E-05
RNF34 -0.081 0.085 - - 0.067 0.015 0.383 3.80E-04 0.383 3.80E-04
SH3TC1 0.051 -0.365 -1.623 -8.284 -0.290 -0.064 -0.513 8.52E-07 -0.513 8.52E-07
SLC19A1 0.033 0.228 1.002 4.858 0.180 0.040 0.521 5.29E-07 0.521 5.29E-07
SLC22A1 0.052 0.150 0.650 0.118 0.026 0.445 2.82E-05 0.445 2.82E-05
SLC22A15 0.042 0.242 1.089 5.435 0.192 0.042 0.394 2.51E-04 0.394 2.51E-04
SOD2 0.052 0.196 0.898 - 0.157 0.034 0.377 4.90E-04 0.377 4.90E-04
STAT3 0.030 0.228 - - 0.180 0.041 0.506 1.24E-06 0.506 1.24E-06
TGFBR2 0.046 0.138 0.616 - 0.109 0.024 0.365 7.56E-04 0.365 7.56E-04
TLR4 0.052 0.242 1.107 - 0.193 0.042 0.409 1.35E-04 0.409 1.35E-04
TNFSF10 0.040 0.192 0.877 - 0.153 0.033 0.395 2.40E-04 0.395 2.40E-04
TP53TG1 -0.029 -0.133 -0.590 -2.993 -0.106 -0.023 -0.404 1.67E-04 -0.404 1.67E-04
ZMIZ1 0.033 0.152 0.681 - 0.121 0.027 0.405 1.59E-04 0.405 1.59E-04
hsa-miR-326 -0.034 -0.139 - - -0.108 -0.026 -0.271 1.38E-02 -0.259 1.87E-02
hsa-miR-181b-5p -0.029 -0.125 -0.525 - -0.098 -0.023 -0.273 1.32E-02 -0.288 8.80E-03
hsa-miR-146a-5p -0.030 -0.127 - - - - -0.310 4.63E-03 -0.336 2.01E-03
hsa-miR-22-3p -0.020 -0.083 -0.342 - -0.065 -0.015 -0.317 3.69E-03 -0.322 3.20E-03
Table S7. Full list of pathway from Bonferroni significant hits using ConsensusPathDB.  
Names Pathways 
BDCM 
BrTHMs 
CHBr3 
CHCl3 
DBCM 
tTHMs 
Validated targets of C-MYC transcriptional repression 
FAS pathway and Stress induction of HSP regulation 
mapkinase signaling pathway 
Apoptosis Modulation and Signaling 
Osteoclast differentiation - Homo sapiens  
Direct p53 effectors 
Influenza A - Homo sapiens  
Insulin Signaling 
BDCM 
BrTHMs 
CHCl3 
DBCM 
tTHMs 
JAK STAT pathway and regulation 
TNF alpha Signaling Pathway 
CXCR4-mediated signaling events 
Transcriptional misregulation in cancer - Homo sapiens  
transcription regulation by methyltransferase of carm1 
Integrated Cancer pathway 
Apoptosis Modulation by HSP70 
Fas 
Apoptosis 
Natural killer cell mediated cytotoxicity - Homo sapiens  
TRAIL signaling pathway 
miR-targeted genes in epithelium - TarBase 
Caspase activation via extrinsic apoptotic signalig pathway 
IL6 
Interferon type I signaling pathways 
Fc-epsilon receptor I signaling in mast cells 
Hepatitis B - Homo sapiens  
IL-3 Signaling Pathway 
ceramide signaling pathway 
IL2 
BDCM 
BrTHMs 
CHBr3 
CHCl3 
tTHMs 
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens  
BDCM 
BrTHMs 
CHBr3 
DBCM 
tTHMs 
Meiosis 
Disease 
BDCM 
BrTHMs 
HIF-1 signaling pathway - Homo sapiens  
CHCl3 
DBCM 
BDCM 
BrTHMs 
CHCl3 
tTHMs 
miR-targeted genes in squamous cell - TarBase 
RHO GTPases Activate NADPH Oxidases 
role of mitochondria in apoptotic signaling 
EGFR1 
Processing and activation of SUMO 
 RAC1 signaling pathway 
BDCM 
BrTHMs 
CHBr3 
DBCM 
keratinocyte differentiation 
Regulation of toll-like receptor signaling pathway 
NOTCH1 Intracellular Domain Regulates Transcription 
Fc epsilon RI signaling pathway - Homo sapiens  
BDCM 
BrTHMs 
DBCM 
tTHMs 
Oxidative Stress Induced Senescence 
Tuberculosis - Homo sapiens  
Toxoplasmosis - Homo sapiens  
miR-targeted genes in lymphocytes - TarBase 
BDCM 
BrTHMs 
CHCl3 
HIV-1 Nef: Negative effector of Fas and TNF-alpha 
Signaling by Rho GTPases 
hiv-1 nef: negative effector of fas and tnf 
Vitamin E metabolism 
BDCM 
CHCl3 
tTHMs 
IL4 
Coregulation of Androgen receptor activity 
JAK STAT MolecularVariation 2 
BDCM 
BrTHMs 
DBCM 
Cellular Senescence 
Hemostasis 
Toll-like receptor signaling pathway 
Toll-like receptor signaling pathway - Homo sapiens  
p38 MAPK signaling pathway 
Cellular responses to stress 
MAPK Cascade 
links between pyk2 and map kinases 
Senescence-Associated Secretory Phenotype (SASP) 
Chagas disease (American trypanosomiasis) - Homo sapiens  
Amyotrophic lateral sclerosis (ALS) - Homo sapiens  
Factors involved in megakaryocyte development and platelet production 
Angiogenesis overview 
EGF-Core 
BCR 
BDCM 
BrTHMs 
tTHMs 
Endocytosis - Homo sapiens  
IL5 
BrTHMs 
CHBr3 
DBCM 
ATF6-alpha activates chaperone genes 
BrTHMs 
DBCM 
tTHMs 
B Cell Receptor Signaling Pathway 
BDCM 
CHCl3 
Nanomaterial induced apoptosis 
CHCl3 
DBCM 
Programmed Cell Death 
CHCl3 
tTHMs 
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor 
alpha (PPARalpha) 
 
mechanism of gene regulation by peroxisome proliferators via ppara 
Steroid biosynthesis - Homo sapiens  
miR-targeted genes in adipocytes - TarBase 
BDCM 
BrTHMs 
Innate Immune System 
Regulation of p38-alpha and p38-beta 
CDC42 signaling events 
Nucleotide-binding domain 
Kit receptor signaling pathway 
tnf/stress related signaling 
BDCM 
tTHMs 
Regulation of Androgen receptor activity 
CHBr3 
DBCM 
Glucocorticoid Receptor Pathway 
BrTHMs 
DBCM 
Measles - Homo sapiens  
TSH signaling pathway 
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids 
Class IB PI3K non-lipid kinase events 
Pathways in cancer - Homo sapiens  
EGF 
repression of WNT target genes 
Non-small cell lung cancer - Homo sapiens  
Nicotinate and Nicotinamide Metabolism 
Leishmaniasis - Homo sapiens  
DBCM 
tTHMs 
TCR 
CHCl3 Regulation of actin dynamics for phagocytic cup formation 
BDCM 
formation of the beta-catenin:TCF transactivating complex 
RHO GTPases activate PKNs 
Retinoic acid receptors-mediated signaling 
p38 mapk signaling pathway 
TNFalpha 
EGF-EGFR Signaling Pathway 
DBCM 
Vitamin B3 (nicotinate and nicotinamide) metabolism 
IL8- and CXCR2-mediated signaling events 
IL3 
rac1 cell motility signaling pathway 
degradation of the rar and rxr by the proteasome 
Regulation of KIT signaling 
fc epsilon receptor i signaling in mast cells 
miR-targeted genes in muscle cell - TarBase 
nf-kb signaling pathway 
Ligand-dependent caspase activation 
Chronic myeloid leukemia - Homo sapiens  
CHBr3 
Aurora C signaling 
Signaling events mediated by focal adhesion kinase 
HDMs demethylate histones 
Synthesis of PG 
Sialic acid metabolism 
Nuclear Receptors Meta-Pathway 
Degradation of beta-catenin by the destruction complex 
BrTHMs 
miR-targeted genes in leukocytes - TarBase 
S1P2 pathway 
Regulation of RAC1 activity 
Leukocyte transendothelial migration - Homo sapiens  
tTHMs 
Alzheimer 
JAK STAT MolecularVariation 1 
Oxidative phosphorylation 
Jak-STAT signaling pathway - Homo sapiens  
EPO Receptor Signaling 
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